DECOFAM COUGH SYRUP

PT ACTAVIS INDONESIA🇸🇬 Health Sciences Authority

Approval Id: 0790cb007fe3348b
Drug Name: DECOFAM COUGH SYRUP
Product Name: DECOFAM COUGH SYRUP
Approval Number: SIN02936P
Approval Date: 1989-05-22
Registrant: TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder: TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: General Sale List
Dosage Form: SYRUP
Dosage: **RECOMMENDED DOSAGE:** Orally administered. Adults :2 teaspoonfuls 3 to 4 times a day.Children :7 – 12 years : 1 teaspoonful 3 to 4 times a day.2 – 6 years : ½ teaspoonful 3 to 4 times a day.
Route Of Administration: ORAL
Indication Info: **INDICATIONS:** This preparation is indicated for cough. Guaiphenesin and Ammonium Chloride to ease coughing out the phlegm. Ephedrine to improve nasal congestion.
Contraindications: **CONTRA-INDICATIONS:** In patients with MAO inhibitor therapy.
Atc Code: R05CA10
Atc Item Name: combinations
Pharma Manufacturer Name: TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path: /organization/teva-pharmaceutical-investments-singapore-pte-ltd

AMMONIUM CHLORIDE

80 mg/5 ml

EPHEDRINE HCl

4 mg/5 ml

GUAIPHENESIN

50 mg/5 ml

AMMONIUM CHLORIDE

80 mg/5 ml

EPHEDRINE HCl

4 mg/5 ml

GUAIPHENESIN

50 mg/5 ml

Approved

Agency

HSA

Country

🇸🇬

Approval Date

May 22, 1989

Approval ID

0790cb007fe3348b

Type

Therapeutic